1. Home
  2. WVE vs VRE Comparison

WVE vs VRE Comparison

Compare WVE & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • VRE
  • Stock Information
  • Founded
  • WVE 2012
  • VRE 1949
  • Country
  • WVE Singapore
  • VRE United States
  • Employees
  • WVE N/A
  • VRE N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • VRE Real Estate Investment Trusts
  • Sector
  • WVE Health Care
  • VRE Real Estate
  • Exchange
  • WVE Nasdaq
  • VRE Nasdaq
  • Market Cap
  • WVE 1.8B
  • VRE 1.5B
  • IPO Year
  • WVE 2015
  • VRE 1994
  • Fundamental
  • Price
  • WVE $11.13
  • VRE $15.66
  • Analyst Decision
  • WVE Strong Buy
  • VRE Buy
  • Analyst Count
  • WVE 10
  • VRE 4
  • Target Price
  • WVE $21.60
  • VRE $18.25
  • AVG Volume (30 Days)
  • WVE 734.1K
  • VRE 312.9K
  • Earning Date
  • WVE 03-05-2025
  • VRE 02-24-2025
  • Dividend Yield
  • WVE N/A
  • VRE 1.67%
  • EPS Growth
  • WVE N/A
  • VRE N/A
  • EPS
  • WVE N/A
  • VRE N/A
  • Revenue
  • WVE $53,610,000.00
  • VRE $293,369,000.00
  • Revenue This Year
  • WVE N/A
  • VRE N/A
  • Revenue Next Year
  • WVE $48.58
  • VRE $4.53
  • P/E Ratio
  • WVE N/A
  • VRE N/A
  • Revenue Growth
  • WVE N/A
  • VRE 11.63
  • 52 Week Low
  • WVE $4.01
  • VRE $13.84
  • 52 Week High
  • WVE $16.74
  • VRE $18.85
  • Technical
  • Relative Strength Index (RSI)
  • WVE 44.53
  • VRE 41.77
  • Support Level
  • WVE $10.79
  • VRE $15.51
  • Resistance Level
  • WVE $11.78
  • VRE $16.18
  • Average True Range (ATR)
  • WVE 0.69
  • VRE 0.28
  • MACD
  • WVE 0.05
  • VRE 0.00
  • Stochastic Oscillator
  • WVE 43.95
  • VRE 29.05

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

Share on Social Networks: